Your Top 100 most-cited badge
A badge for your website, a sentence for your CV, and a permanent page where anyone can check the rank.
The article
VP6-2022: Adjuvant pertuzumab and trastuzumab in patients with early HER-2 positive breast cancer in APHINITY: 8.4 years' follow-up
Sibylle Loibl, Jacek Jassem, Amir Sonnenblick, Damien Parlier, Eric P. Winer, Jonas C. S. Bergh and 14 more
- Rank
- 75 of 3,616
- Percentile
- top 2.1%
- Where
- Annals of Oncology, 2022
- Citations
- 52
From the 2022 list, OpenAlex counts as of 2026-10-29.
Prefer not to be listed? The same link lets you withhold your name on every list; the article stays, your name does not. Questions: team@avidnote.com.